CyclingGuy Posted - 9 hours ago

$ITCI Any day now results of 2nd trial will be released and $100+. Some analysts believe 90% probability good 2nd trial.

Stock_Titan Posted - 04/30/24

$ITCI Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast https://www.stocktitan.net/news/ITCI/intra-cellular-therapies-to-host-first-quarter-2024-financial-88qwv4i0uk80.html

CyclingGuy Posted - 04/26/24

$ITCI Funny how the sentiment meter went from green to red in just one day.

CyclingGuy Posted - 04/24/24

$ITCI Underwriters bought all their shares. NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it has completed the sale of an additional 1,027,397 shares of its common stock at a public offering price of $73.00 per share on April 24, 2024, pursuant to the full exercise of the option granted by Intra-Cellular Therapies to the underwriters in connection with its previously announced public offering of 6,849,316 shares of common stock, which closed on April 22, 2024.

Stock_Titan Posted - 04/24/24

$ITCI Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares https://www.stocktitan.net/news/ITCI/intra-cellular-therapies-announces-closing-of-575-million-public-gnicv2ju3j5m.html

Clovus33 Posted - 04/23/24

$ITCI nice rally off recent lows at 72 level I would have bought more if I had the cash under 72. Why cause basis is 56 will continue to sell covered calls into the future.

CyclingGuy Posted - 04/23/24

$ITCI On Tuesday, Intra-Cellular Therapies (NASDAQ:ITCI) saw its price target increased by Canaccord Genuity from $100.00 to $107.00... https://www.investing.com/news/company-news/intracellular-shares-target-raised-by-canaccord-on-mdd-study-results-93CH-3390642

Capitulation_0 Posted - 04/22/24

$ITCI patent is usually 20 years after filing... Yes, this drug has been around the block a bit yet it was extended to 2033. And it takes 2 years before generic drugs hit the market. This gives a potential buyer 10 year to realize say 20B-30B in revenue. This does not factoring in the pipeline which has a lot of promise.

Capitulation_0 Posted - 04/22/24

$ITCI Caplyta: average 4.9-point MADRS reduction Vraylar: two different dosage strengths of the drug posted 2.4- and 2.9-point. AbbVie CEO Rick Gonzalez: Vraylar’s peak sales potential at $4 billion. So why are these analyst putting $1.1B- 1.3B peak sales when Vraylar is $4B

Capitulation_0 Posted - 04/22/24

$ITCI My guess is that BPs won't wait for 2nd MDD readout. BPs will take this out before the 2nd readout...(4.9 point reduction v. placebo; p<0.0001; Cohen’s d effect size (ES)= 0.61) This stock should be in the high 80s... low 90s at the moment.

Doozio Posted - 04/22/24

$ITCI let’s go huckleberry riding thru da $$$.

Capitulation_0 Posted - 04/22/24

$ITCI Mizuho: Raising PT to $96 from $82 Needham: Raises $90 from $82 BofA: $91 from $82 Baird: $102 from $83 Cowen: $90 MS: $92 from $82 GS: $77 from $67 (idiots) My target: $100 with $125 BO

Capitulation_0 Posted - 04/22/24

$ITCI Many companies have to run 4,5,6 trails in MDD to get positive results. IP issue is overstated. Patent protection till 2035 is what Mizuho expects after doing a thorough research... I expect a BP to make a bid on this after better than expected MDD data.. $120-130

Quantumup Posted - 04/22/24

Mizuho raised the PT on $ITCI to $96 was $82/Buy + increased Caplyta's probability of success (PoS) to 80% was 65% and also their peak risk-unadjusted estimates to $1.9B from $1.6B, in major depressive disorder (MDD), on stronger than expected data from the Co's first of 2 Ph3's.

Capitulation_0 Posted - 04/22/24

$ITCI Antidepressants represents 4.2 percent of all pharmaceutical sales globally.

Capitulation_0 Posted - 04/22/24

$ITCI wait for 2nd readout, additional 2B gets added to the BO price. BP's should be able to discern the probability of the readout.

Capitulation_0 Posted - 04/22/24

$ITCI Mizuho's Graig Suvannavejh stated that they did a deep dive into the Patent along with Patent attorneys and stated that based on their analysis and work, the Patent should hold up to 2034-3037... If BP's also come to that conclusion, this is a BO waiting to happen. There's a 2nd readout for MDD in June or so. Huge market for a BP. 12B+ BO

Clovus33 Posted - 04/22/24

$ITCI Study Uncovers Serious Side Effects From Common Dementia Drugs https://www.sciencealert.com/study-uncovers-serious-side-effects-from-common-dementia-drugs

CcJenson Posted - 04/22/24

$ITCI anyone else see that quick bounce off 72 at 938ish on Yahoo finance? That was weird

Capitulation_0 Posted - 04/22/24

$ITCI Analyst are confident that IP can be extended. MDD is a huge indication that every BPs should be drooling over.

CyclingGuy Posted - 04/22/24

$ITCI Intra-Cellular Therapies (ITCI) PT Raised to $96 at Mizuho https://www.streetinsider.com/Analyst+Comments/Intra-Cellular+Therapies+%28ITCI%29+PT+Raised+to+%2496+at+Mizuho/23093103.html

FlynancialAnalyst Posted - 04/21/24

$ITCI $7.05B mc $XLV drug manufacturer sneaking in an accumulation wk and close back above fresh gold-cross... knocking on ATHs... $100 🧲 98.61% institutionally owned following a steady 2 year trend higher TrendEdge.app/asset/ITCI

ColbyJax Posted - 04/20/24

$ITCI Below 73$ is the target entry point for sure, but how low do you think this will go before it climbs again? I initially thought 68$, but now I’m thinking we’ll be lucky if we can get some at 70$. I purchased back for a basis around 71.5 so far. I don’t like being apart from this stock for long. This is the best management team I’ve ever seen.

Capitulation_0 Posted - 04/19/24

$ITCI bought some more today... also $CYTK I think both gets BO sometime this year.

Capitulation_0 Posted - 04/19/24

$ITCI why is prospect of MDD huge? Vraylar generated $2B in 2022 (+17.9% from 2021). Sales are expected to increase by 30-35% in 2023. Vrylar was approved as adjuvant for MDD at end of 2022.

johnyyywardyy Posted - 04/19/24

$ITCI bloody next week

Fedtegreve Posted - 04/19/24

$ITCI do we have mvp @Deckard1908 with latest script numbers?

Idvst8 Posted - 04/19/24

$ITCI - Derisked. Top 5 buyout candidate. $12-$15 Billion minimum.

Capitulation_0 Posted - 04/19/24

$ITCI Data was better than expected by all measures and bodes well. Vraylar is expected to do 4B peak sales. Dumb action all around.

Capitulation_0 Posted - 04/19/24

$ITCI Mizuho's Graig Suvannavejh is very positive on this name. He's worked on M&A side. He thinks that this is attractive because it's not uncommon for 4-5 trails in MDD. 24-25M TAM. Huge market.